Patient understanding of the importance of statin use in the perioperative period

Efrain I. Cubillo, David M. Rosenfeld, Susan G. Hagstrom, Francis L. Hu, John H. Demenkoff, Meng Ru Cheng, Terrence L. Trentman

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective Perioperative hydroxy-3-methyl glutaryl coenzyme A reductase inhibitors (statins) have been shown to decrease morbidity and mortality after noncardiac surgery. The objective of this study was to assess patient understanding of the potential benefits of perioperative statins in a select population already on chronic therapy. A secondary aim was to determine the frequency with which patients recalled having a discussion with their provider regarding perioperative statins. Design Survey. Setting Teaching hospital. Participants Patients taking daily statins presenting to a preoperative medical evaluation clinic were offered a 12-question survey that assessed their understanding of the potential benefit of taking the medication in the perioperative period. Interventions None. Measurements and Main Results One hundred thirty-two patients completed the questionnaire. The mean age was 68.3 years (standard deviation, 9.0); 42% were female. The most frequent surgical referral to the clinic was orthopedics, at 36%. The most common statin prescribed was atorvastatin, in 35% of patients. Twenty-seven percent of patients (n = 36) recognized that perioperative statins are beneficial; 44% of these patients (n = 14) cited decreased cholesterol during the procedure as the reason, representing 12% of the total sampled population. Twenty-two percent (n = 8) of those recognizing the benefit of perioperative statins identified a decrease in the risk of heart attack or death as the reason. This represented only 6% of the total sample. One percent of surgeons mentioned statins in relation to the planned surgery; 2% of primary or prescribing physicians mentioned the medication in relation to surgery. Conclusions This study suggested low patient understanding of the potential importance and reasons for perioperative statins. In addition, this study also suggested that the information regarding the importance of perioperative statins is not being relayed to the patient at the level of the surgeon or primary care physician. All physicians involved in perioperative care can offer improved patient education to promote compliance with statin therapy in hopes of a favorable impact on perioperative outcomes.

Original languageEnglish (US)
Pages (from-to)670-677
Number of pages8
JournalJournal of Cardiothoracic and Vascular Anesthesia
Volume29
Issue number3
DOIs
StatePublished - Jun 1 2015

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Perioperative Period
Physicians
Perioperative Care
Primary Care Physicians
Patient Education
Teaching Hospitals
Population
Orthopedics
Oxidoreductases
Referral and Consultation
Myocardial Infarction
Cholesterol

Keywords

  • cardioprotection
  • hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase inhibitor
  • revised cardiac index
  • statins

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Anesthesiology and Pain Medicine

Cite this

Cubillo, E. I., Rosenfeld, D. M., Hagstrom, S. G., Hu, F. L., Demenkoff, J. H., Cheng, M. R., & Trentman, T. L. (2015). Patient understanding of the importance of statin use in the perioperative period. Journal of Cardiothoracic and Vascular Anesthesia, 29(3), 670-677. https://doi.org/10.1053/j.jvca.2014.10.021

Patient understanding of the importance of statin use in the perioperative period. / Cubillo, Efrain I.; Rosenfeld, David M.; Hagstrom, Susan G.; Hu, Francis L.; Demenkoff, John H.; Cheng, Meng Ru; Trentman, Terrence L.

In: Journal of Cardiothoracic and Vascular Anesthesia, Vol. 29, No. 3, 01.06.2015, p. 670-677.

Research output: Contribution to journalArticle

Cubillo, EI, Rosenfeld, DM, Hagstrom, SG, Hu, FL, Demenkoff, JH, Cheng, MR & Trentman, TL 2015, 'Patient understanding of the importance of statin use in the perioperative period', Journal of Cardiothoracic and Vascular Anesthesia, vol. 29, no. 3, pp. 670-677. https://doi.org/10.1053/j.jvca.2014.10.021
Cubillo, Efrain I. ; Rosenfeld, David M. ; Hagstrom, Susan G. ; Hu, Francis L. ; Demenkoff, John H. ; Cheng, Meng Ru ; Trentman, Terrence L. / Patient understanding of the importance of statin use in the perioperative period. In: Journal of Cardiothoracic and Vascular Anesthesia. 2015 ; Vol. 29, No. 3. pp. 670-677.
@article{7f7929de805b4c6dbdaa1f334609bdce,
title = "Patient understanding of the importance of statin use in the perioperative period",
abstract = "Objective Perioperative hydroxy-3-methyl glutaryl coenzyme A reductase inhibitors (statins) have been shown to decrease morbidity and mortality after noncardiac surgery. The objective of this study was to assess patient understanding of the potential benefits of perioperative statins in a select population already on chronic therapy. A secondary aim was to determine the frequency with which patients recalled having a discussion with their provider regarding perioperative statins. Design Survey. Setting Teaching hospital. Participants Patients taking daily statins presenting to a preoperative medical evaluation clinic were offered a 12-question survey that assessed their understanding of the potential benefit of taking the medication in the perioperative period. Interventions None. Measurements and Main Results One hundred thirty-two patients completed the questionnaire. The mean age was 68.3 years (standard deviation, 9.0); 42{\%} were female. The most frequent surgical referral to the clinic was orthopedics, at 36{\%}. The most common statin prescribed was atorvastatin, in 35{\%} of patients. Twenty-seven percent of patients (n = 36) recognized that perioperative statins are beneficial; 44{\%} of these patients (n = 14) cited decreased cholesterol during the procedure as the reason, representing 12{\%} of the total sampled population. Twenty-two percent (n = 8) of those recognizing the benefit of perioperative statins identified a decrease in the risk of heart attack or death as the reason. This represented only 6{\%} of the total sample. One percent of surgeons mentioned statins in relation to the planned surgery; 2{\%} of primary or prescribing physicians mentioned the medication in relation to surgery. Conclusions This study suggested low patient understanding of the potential importance and reasons for perioperative statins. In addition, this study also suggested that the information regarding the importance of perioperative statins is not being relayed to the patient at the level of the surgeon or primary care physician. All physicians involved in perioperative care can offer improved patient education to promote compliance with statin therapy in hopes of a favorable impact on perioperative outcomes.",
keywords = "cardioprotection, hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase inhibitor, revised cardiac index, statins",
author = "Cubillo, {Efrain I.} and Rosenfeld, {David M.} and Hagstrom, {Susan G.} and Hu, {Francis L.} and Demenkoff, {John H.} and Cheng, {Meng Ru} and Trentman, {Terrence L.}",
year = "2015",
month = "6",
day = "1",
doi = "10.1053/j.jvca.2014.10.021",
language = "English (US)",
volume = "29",
pages = "670--677",
journal = "Journal of Cardiothoracic and Vascular Anesthesia",
issn = "1053-0770",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Patient understanding of the importance of statin use in the perioperative period

AU - Cubillo, Efrain I.

AU - Rosenfeld, David M.

AU - Hagstrom, Susan G.

AU - Hu, Francis L.

AU - Demenkoff, John H.

AU - Cheng, Meng Ru

AU - Trentman, Terrence L.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Objective Perioperative hydroxy-3-methyl glutaryl coenzyme A reductase inhibitors (statins) have been shown to decrease morbidity and mortality after noncardiac surgery. The objective of this study was to assess patient understanding of the potential benefits of perioperative statins in a select population already on chronic therapy. A secondary aim was to determine the frequency with which patients recalled having a discussion with their provider regarding perioperative statins. Design Survey. Setting Teaching hospital. Participants Patients taking daily statins presenting to a preoperative medical evaluation clinic were offered a 12-question survey that assessed their understanding of the potential benefit of taking the medication in the perioperative period. Interventions None. Measurements and Main Results One hundred thirty-two patients completed the questionnaire. The mean age was 68.3 years (standard deviation, 9.0); 42% were female. The most frequent surgical referral to the clinic was orthopedics, at 36%. The most common statin prescribed was atorvastatin, in 35% of patients. Twenty-seven percent of patients (n = 36) recognized that perioperative statins are beneficial; 44% of these patients (n = 14) cited decreased cholesterol during the procedure as the reason, representing 12% of the total sampled population. Twenty-two percent (n = 8) of those recognizing the benefit of perioperative statins identified a decrease in the risk of heart attack or death as the reason. This represented only 6% of the total sample. One percent of surgeons mentioned statins in relation to the planned surgery; 2% of primary or prescribing physicians mentioned the medication in relation to surgery. Conclusions This study suggested low patient understanding of the potential importance and reasons for perioperative statins. In addition, this study also suggested that the information regarding the importance of perioperative statins is not being relayed to the patient at the level of the surgeon or primary care physician. All physicians involved in perioperative care can offer improved patient education to promote compliance with statin therapy in hopes of a favorable impact on perioperative outcomes.

AB - Objective Perioperative hydroxy-3-methyl glutaryl coenzyme A reductase inhibitors (statins) have been shown to decrease morbidity and mortality after noncardiac surgery. The objective of this study was to assess patient understanding of the potential benefits of perioperative statins in a select population already on chronic therapy. A secondary aim was to determine the frequency with which patients recalled having a discussion with their provider regarding perioperative statins. Design Survey. Setting Teaching hospital. Participants Patients taking daily statins presenting to a preoperative medical evaluation clinic were offered a 12-question survey that assessed their understanding of the potential benefit of taking the medication in the perioperative period. Interventions None. Measurements and Main Results One hundred thirty-two patients completed the questionnaire. The mean age was 68.3 years (standard deviation, 9.0); 42% were female. The most frequent surgical referral to the clinic was orthopedics, at 36%. The most common statin prescribed was atorvastatin, in 35% of patients. Twenty-seven percent of patients (n = 36) recognized that perioperative statins are beneficial; 44% of these patients (n = 14) cited decreased cholesterol during the procedure as the reason, representing 12% of the total sampled population. Twenty-two percent (n = 8) of those recognizing the benefit of perioperative statins identified a decrease in the risk of heart attack or death as the reason. This represented only 6% of the total sample. One percent of surgeons mentioned statins in relation to the planned surgery; 2% of primary or prescribing physicians mentioned the medication in relation to surgery. Conclusions This study suggested low patient understanding of the potential importance and reasons for perioperative statins. In addition, this study also suggested that the information regarding the importance of perioperative statins is not being relayed to the patient at the level of the surgeon or primary care physician. All physicians involved in perioperative care can offer improved patient education to promote compliance with statin therapy in hopes of a favorable impact on perioperative outcomes.

KW - cardioprotection

KW - hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase inhibitor

KW - revised cardiac index

KW - statins

UR - http://www.scopus.com/inward/record.url?scp=84930084027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930084027&partnerID=8YFLogxK

U2 - 10.1053/j.jvca.2014.10.021

DO - 10.1053/j.jvca.2014.10.021

M3 - Article

C2 - 25704325

AN - SCOPUS:84930084027

VL - 29

SP - 670

EP - 677

JO - Journal of Cardiothoracic and Vascular Anesthesia

JF - Journal of Cardiothoracic and Vascular Anesthesia

SN - 1053-0770

IS - 3

ER -